GLP-1 Receptor Agonists: From Diabetes Drugs to a New Era of Metabolic & Systemic Medicine GLP-1 receptor agonists (GLP-1RAs) represent one of the most transformative therapeutic advances in modern medicine
Our personalized program begins with a consultation with a nurse practitioner who will: Following lab results, a nurse practitioner will outline your customized weight loss plan, answer questions, and administer your initial injection, with dosage adjustments based on your progress and any side effects
Participants who switched from tirzepatide to placebo regained approximately 14% of their body weight over 52 weeks, while those who continued tirzepatide maintained their weight loss and even achieved modest additional reductions
All-inclusive, no membership: consultation, prescription, compounded medication, and shipping in one bill
Exenatide market share has shrunk rapidly since 2019 as longer lasting and more effective GLP-1s like semaglutide and tirzepatide have arrived, and with them, reports of anti-addictive effects
While the body produces it, several factors can overwhelm its capacity to keep up: Aging: Natural production begins to taper off as early as your 20s or 30s